ARCHIVES

Congress Plans to Accelerate Development of Drugs, Devices

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

Ohio State Becomes 18th Comprehensive Center; UCLA Needs Only To Overcome “Minor” Problems

April 16, 1976

ODAC Recommends Femara Campath For FDA Approval.

January 5, 2001

DCE Board Approves concept For New Studies On Black, White Differences In Cancer Rates

July 13, 1984

DeVita Reshuffling NCI Office Space

April 18, 1980

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

DCPC advisors OK 16 Year Trial Of Screening Methods

February 15, 1991